drug protocol number
MO22223
drug sponsor
Roche
drug study
Bevacizumab+ Capecitabine
drug trial site
King Abdulaziz Hospital and Oncology Center (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Fahad Specialist Hospital (Dammam)
drug status
Terminated
drug phase